Cleveland Clinic researcher links thyroid cancer to genetic mutations

Research led by the Cleveland Clinic‘s Dr. Charis Eng has led to the discovery of three genetic mutations that are linked to thyroid cancer.

The research involved nearly 3,000 patients with Cowden syndrome, a rare disorder characterized by multiple noncancerous, tumor-like growths that is related to an increased risk of breast and thyroid cancer, according to a statement from the Clinic.

Cleveland Clinic researchers found that mutations in a gene called the “PTEN” are the foundation of Cowden syndrome. PTEN is a tumor suppressor gene that helps direct the growth and division of cells.

presented by

Sponsored Post

Join us June 17th as we explore how a unified identity strategy, spanning patients, providers, and emerging solutions like Verato Identity Network enables accurate attribution, strengthens interoperability, and ultimately drives VBC success.

By Verato and MedCity News

The researchers recommend that the thyroids of children with PTEN mutation-causing, Cowden Syndrome-related disease receive increased surveillance.

Eng placed at No. 31 in MedCity News’ list of the “The 50 best Cleveland Clinic doctors. Ever.”